We are live on ! Find out more
NDRM

NeuroDerm Ltd. Ordinary Shares
NDRM

Delisted

NDRM was delisted on the 17th of October, 2017.

Back to rankings

73 hedge funds and large institutions have $418M invested in NeuroDerm Ltd. Ordinary Shares in 2017 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 29 increasing their positions, 16 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,497% more call options, than puts

Call options by funds: $7.89M | Put options by funds: $494K

81% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 16

25% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 12

18% more capital invested

Capital invested by funds: $354M → $418M (+$64M)

4% more funds holding

Funds holding: 70 → 73 (+3)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
73
Holders Change
+3
Holders Change %
+4.29%
% of All Funds
1.82%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
15
Increased
29
Reduced
16
Closed
12
Calls
$7.89M
Puts
$494K
Net Calls
+$7.4M
Net Calls Change
+$974K

Top Buyers

Rank Fund Capital Flow
1
Viking Global Investors
Viking Global Investors
Connecticut
+$18.4M
2
RPAM
Rhenman & Partners Asset Management
Sweden
+$12M
3
Wells Fargo
Wells Fargo
California
+$9.65M
4
Citadel Advisors
Citadel Advisors
Florida
+$5.62M
5
RSCM
Rock Springs Capital Management
Maryland
+$3.98M

Top Sellers

Rank Fund Capital Flow
1
ACA
Avoro Capital Advisors
New York
-$14.1M
2
ACP
Acuta Capital Partners
California
-$9.77M
3
RG
Redmile Group
California
-$9.56M
4
Millennium Management
Millennium Management
New York
-$6.32M
5
CLCM
Crawford Lake Capital Management
New Jersey
-$4.57M
Name Holding Trade Value Shares
Change 		Change in
Stake
MC
51
Menta Capital
California
$344K -$346K -13,376 -54%
Morgan Stanley
52
Morgan Stanley
New York
$332K -$76.6K -2,957 -21%
TI
53
Trexquant Investment
Connecticut
$316K +$274K +10,582 New
NSEDCP
54
NJ State Employees Deferred Compensation Plan
New Jersey
$299K – – –
Deutsche Bank
55
Deutsche Bank
Germany
$283K -$600K -23,180 -71%
OC
56
Oppenheimer & Co
New York
$252K +$777 +30 +0.4%
Bank of America
57
Bank of America
North Carolina
$250K +$20.2K +780 +10%
HighTower Advisors
58
HighTower Advisors
Illinois
$226K -$41.4K -1,600 -17%
EMG
59
ETF Managers Group
New Jersey
$210K +$182K +7,008 New
Vanguard Group
60
Vanguard Group
Pennsylvania
$210K +$182K +7,015 New
VanEck Associates
61
VanEck Associates
New York
$141K +$12.1K +468 +11%
IA
62
IFP Advisors
Florida
$105K +$10.4K +400 +13%
UBS Group
63
UBS Group
Switzerland
$70K +$43K +1,659 +240%
Barclays
64
Barclays
United Kingdom
$32K +$907 +35 +3%
PCM
65
Prelude Capital Management
New York
$26K +$22.7K +876 New
Citigroup
66
Citigroup
New York
$22K +$18.6K +719 New
Royal Bank of Canada
67
Royal Bank of Canada
Ontario, Canada
$21K – – –
JP Morgan Chase
68
JP Morgan Chase
New York
$18K – – –
AIM
69
Advantage Investment Management
Iowa
$15K – – –
Legal & General Group
70
Legal & General Group
United Kingdom
$9K -$5.96K -230 -43%
AG
71
Advisor Group
Arizona
$7K +$6.48K +250 New
CG
72
Cutler Group
California
$2K +$2.59K +100 New
FWM
73
Focused Wealth Management
New York
$1K – – –
EI
74
EAM Investors
California
– -$2.17M -81,642 Closed
Renaissance Technologies
75
Renaissance Technologies
New York
– -$2.11M -79,626 Closed
1 2
3
4

NDRM Hedge Fund Activity: Q2 2017 in Review

73 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in NeuroDerm Ltd. Ordinary Shares (NDRM) for Q2 2017, worth a combined $418M — up 18% from $354M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new NDRM positions and 12 closed out — a net gain of 3 holders — while 29 added to existing stakes and 16 trimmed.

The largest buyer was Viking Global Investors, opening a new position worth an estimated $18.4M. The largest seller was Avoro Capital Advisors, cutting an estimated $14.1M.

  • 73 institutional investors held NeuroDerm Ltd. Ordinary Shares (NDRM) as of Q2 2017, up from 70 in Q1 2017.
  • Funds reported $418M of NeuroDerm Ltd. Ordinary Shares stock for Q2 2017, up 18% quarter-over-quarter.
  • 15 funds opened new NeuroDerm Ltd. Ordinary Shares positions in Q2 2017 and 12 closed out, a net change of +3 holders.
  • The largest NeuroDerm Ltd. Ordinary Shares buyer in Q2 2017 was Viking Global Investors, an estimated $18.4M added.
  • The largest NeuroDerm Ltd. Ordinary Shares seller in Q2 2017 was Avoro Capital Advisors, an estimated $14.1M sold.

Based on aggregated 13F filings for Q2 2017.